SecBot SecBot

MYO

MYOMO, INC.
NYSE· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. DE· CIK 0001369290 Healthcare & Medical Devices
$1.20 −0.01 (−0.83%)
Oct 26 4:00 PM ET · prev $1.21
Market cap
$48.3M
Nano cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
$3.00
+150% · range $1.70–10.50
Next earnings
Nov 11
in 15 days · EPS est. −$0.07
1 year
+12.1%
from $1.07 · Oct 27
30 days
−23.1%
from $1.56
52-week range
$0.6400–1.86
−35% from high · low Mar 30
Avg volume 20D
244.9K
shares / day
Short interest
🔒 Subscribers only
Insider net
+$151.7K
3 buyers · 3 sellers · since Mar 13
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
7
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 11, 2026
Strongest NEUTRAL David A. Henry, an officer of Myomo, Inc., filed a Form 144 notice of intent to sell 3,133 shares of common…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B Mar 13 to Mar 16 2 days of insider buys: $65.1K by 2 insiders, avg $0.7074
  • B May 14 to May 18 3 days of insider buys: $242.2K by 2 insiders, avg $0.8767
  • R May 19 Two directors at Myomo (MYO) acquired ~43K shares in open-market pur…
  • S May 27 to May 28 2 days of insider sells: $32.2K by 1 insider, avg $1.01
  • X Aug 14 Short interest falls 39.1% to 1.12M
  • S Aug 20 1 insider sell $60.2K at $1.73
  • S Sep 2 1 insider sell $21.1K at $1.41
  • S Sep 11 1 insider sell $39.8K at $1.27

Signal stack

Where each data set points today.

  • InsidersMIXED

    3 insiders bought $382.9K at an average $0.8838. 3 insiders sold $231.1K. Price is 36% above their cost.

  • InstitutionsMIXED

    Q2 2026: 14 added (0 new), 11 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.070 → −$0.073 over 90 days. 2 up, 1 down in 30 days.

  • TrendDOWNTREND

    18% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
VANGUARD CAPITAL MANAGEMENT LLCADD1,636,570$1.7M
UBS Group AGADD413,679$430.2K
GEODE CAPITAL MANAGEMENT, LLCTRIM344,417$358.3K
BlackRock, Inc.NEAR_EXIT223,217$232.1K
BNP PARIBAS FINANCIAL MARKETSDOUBLED139,194$144.8K
IEQ CAPITAL, LLCDOUBLED127,749$132.9K
SUSQUEHANNA INTERNATIONAL GROUP, LLPDOUBLED120,791$125.6K
STATE STREET CORPTRIM105,875$110.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy1Buy7Hold1Sell0Strong Sell0
12-month targets · 5 analysts

Price is below the lowest target. Median implies +150%.Targets as of Oct 27, 2026.

Recent actions
DateFirmActionRating
Aug 27, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
Jun 8, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$382.9K
bought · 3 insiders
$231.1K
sold · 3 insiders
+35.8%
vs their $0.8838 cost
DateInsiderTypeValue
Oct 13, 2026
Kovelman Harry
Chief Medical Officer
AWARD32,500 sh
Oct 13, 2026
GUDONIS PAUL R
Chief Executive Officer
AWARD71,250 sh
Oct 13, 2026
HENRY DAVID A
Chief Financial Officer
AWARD51,250 sh
Oct 12, 2026
McClure Mary-Katherine Hale
Chief Commericial Officer
AWARD275,000 sh
Oct 12, 2026
HENRY DAVID A
Chief Financial Officer
TAX W/H$4.3K
Oct 9, 2026
GUDONIS PAUL R
Chief Executive Officer
AWARD8,363 sh
Oct 9, 2026
HENRY DAVID A
Chief Financial Officer
AWARD6,272 sh
Sep 11, 2026
Kovelman Harry
Chief Medical Officer
SELL$20.1K

Earnings setup

Estimates
Nov 11
reports in 15 days
−$0.07
EPS estimate, this quarter
−5%
estimate change, 90 days
2↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.07-$0.08–-$0.07+8.3%$11.5M
Next Q-$0.07-$0.08–-$0.06-16.7%$12.3M
Current FY-$0.31-$0.32–-$0.30+3.2%$45.6M
Next FY-$0.22-$0.27–-$0.17+13.2%$51.2M

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
David A. Henry, an officer of Myomo, Inc., filed a Form 144 notice of intent to sell 3,133 shares of common stock…
144 — Impact 2/10
Oct 13, 2026 Insider
Kovelman Harry was granted 32,500 shares
Chief Medical Officer
Oct 13, 2026 Insider
GUDONIS PAUL R was granted 71,250 shares
Chief Executive Officer
Oct 13, 2026 Insider
HENRY DAVID A was granted 51,250 shares
Chief Financial Officer
Aug 14, 2026 Short interest report
Short Interest: MYO down 39% to 1.1M shares
Settlement 2026-08-14 | Days to cover: 1.26 | ≈2.84% of shares outstanding (est.)
Jun 30, 2026 Inst.
VANGUARD CAPITAL MANAGEMENT LLC — ADD
1,636,570 shares ($1.7M)
Jun 30, 2026 Inst.
UBS Group AG — ADD
413,679 shares ($430.2K)
Jun 26, 2026 SEC
Myomo held its 2026 Annual Meeting on June 25, 2026, with stockholders approving all seven proposals, including the…
8-K — Impact 3/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 11, 2026
Earnings date
MYO Q3 2026 Earnings Scheduled — 2026-11-11
Recent
Aug 14, 2026
Short interest
Short Interest: MYO down 39% to 1.1M shares
Settlement 2026-08-14 | Days to cover: 1.26 | ≈2.84% of shares outstanding (est.)
Aug 5, 2026
Earnings date
MYO Q2 2026 Earnings Scheduled — 2026-08-05
Jul 31, 2026
Short interest
Short Interest: MYO down 23% to 1.8M shares
Settlement 2026-07-31 | Days to cover: 5.61 | ≈4.66% of shares outstanding (est.)
Jun 30, 2026
Short interest
Short Interest: MYO down 26% to 2.4M shares
Settlement 2026-06-30 | Days to cover: 1.66 | ≈6.31% of shares outstanding (est.)
May 13, 2026
Earnings date
MYO Q1 2026 Earnings Scheduled — 2026-05-13

SecBot reports

7 filings · 2 bullish · 0 bearish · 5 neutral
All MYO filing & press-release reports (7)